Medexus Pharmaceuticals is a specialty pharmaceutical company based in Canada that acquires, licenses and commercializes medicines for niche and rare diseases. Its portfolio includes treatments for inflammatory conditions such as rheumatoid arthritis, a therapy for hemophilia, and an imaging agent used during brain tumor surgery. The company serves patients and healthcare providers, mainly in North America, through partnerships with larger drug developers and by marketing its products directly.
On this site Medexus Pharmaceuticals Inc appears as a stock on the Toronto Stock Exchange (Canada), code MDP, with prices in Canadian dollars (CAD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Strong price profile
Ranks #121 of 870 on the Toronto Stock Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Canada yet.
TrendStrong
86/100
Trading above its long-term averages and near its highs.
See the numbers →
Above 200-day average20.5%
From 52-week high-8.8%
MomentumStrong
76/100
Rising faster than most stocks on this exchange.
See the numbers →
3-month return0.2%
6-month return22.7%
12-month, skipping last month77.2%
Stability (higher is calmer)Strong
72/100
Calmer than most: low volatility and shallow drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)38.0%
Worst drawdown, 1 year (smaller is calmer)-13.4%
LiquidityWeak
33/100
Thinly traded: prices can jump and exits can be hard.
See the numbers →
Avg daily value traded0.21M CAD
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Canada when fundamentals data for this market is added. All Canada stocks.
52-wk range 2.510 – 5.500Daily closes, split-adjusted
Signals
50-day average5.021
200-day average4.124
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.151
Technical summary
Daily
Bullish
9 bullish · 2 neutral · 5 bearish
Weekly
Strongly bullish
9 bullish · 1 neutral · 2 bearish
Monthly
Strongly bullish
7 bullish · 1 neutral · 0 bearish
Moving averages (daily)
SMA 10
4.90
Bullish
EMA 10
4.92
Bullish
SMA 20
4.90
Bullish
EMA 20
4.93
Bullish
SMA 50
5.02
Bearish
EMA 50
4.94
Bullish
SMA 100
4.87
Bullish
EMA 100
4.76
Bullish
SMA 200
4.12
Bullish
EMA 200
4.30
Bullish
Oscillators (daily)
RSI (14)
51.53
Neutral
MACD (12, 26)
-0.02
Bearish
Momentum (12)
-0.40
Bearish
Stochastic %K (14)
84.85
Bearish
Williams %R (14)
-15.15
Bearish
CCI (20)
49.97
Neutral
Pivot points (classic, last session)
S3
4.74
S2
4.78
S1
4.88
Pivot
4.92
R1
5.02
R2
5.06
R3
5.16
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in CAD. Educational only, not financial advice.
